Roaten JB - Search Results

1

Molecular models of N-benzyladriamycin-14-valerate (AD 198) in complex with the phorbol ester-binding C1b domain of protein kinase C-delta.

Roaten JB, Kazanietz MG, Sweatman TW, Lothstein L, Israel M, Parrill AL. Roaten JB, et al. J Med Chem. 2001 Mar 29;44(7):1028-34. doi: 10.1021/jm000289v. J Med Chem. 2001. PMID: 11297449

2

Novel extranuclear-targeted anthracyclines override the antiapoptotic functions of Bcl-2 and target protein kinase C pathways to induce apoptosis.

Barrett CM, Lewis FL, Roaten JB, Sweatman TW, Israel M, Cleveland JL, Lothstein L. Barrett CM, et al. Among authors: roaten jb. Mol Cancer Ther. 2002 May;1(7):469-81. Mol Cancer Ther. 2002. PMID: 12479265

3

Interaction of the novel anthracycline antitumor agent N-benzyladriamycin-14-valerate with the C1-regulatory domain of protein kinase C: structural requirements, isoform specificity, and correlation with drug cytotoxicity.

Roaten JB, Kazanietz MG, Caloca MJ, Bertics PJ, Lothstein L, Parrill AL, Israel M, Sweatman TW. Roaten JB, et al. Mol Cancer Ther. 2002 May;1(7):483-92. Mol Cancer Ther. 2002. PMID: 12479266

4

Catalytic inhibition of DNA topoisomerase II by N-benzyladriamycin (AD 288).

Lothstein L, Suttle DP, Roaten JB, Koseki Y, Israel M, Sweatman TW. Lothstein L, et al. Among authors: roaten jb. Biochem Pharmacol. 2000 Dec 1;60(11):1621-8. doi: 10.1016/s0006-2952(00)00472-x. Biochem Pharmacol. 2000. PMID: 11077044

5

Ca2+/calmodulin-dependent protein kinase II and cytosolic phospholipase A2 contribute to mitogenic signaling in myeloblastic leukemia U-937 cells.

Muthalif MM, Ljuca F, Roaten JB, Pentapaty N, Uddin MR, Malik KU. Muthalif MM, et al. Among authors: roaten jb. J Pharmacol Exp Ther. 2001 Jul;298(1):272-8. J Pharmacol Exp Ther. 2001. PMID: 11408552

6

Nonaccidental trauma is a major cause of morbidity and mortality among patients at a regional level 1 pediatric trauma center.

Roaten JB, Partrick DA, Nydam TL, Bensard DD, Hendrickson RJ, Sirotnak AP, Karrer FM. Roaten JB, et al. J Pediatr Surg. 2006 Dec;41(12):2013-5. doi: 10.1016/j.jpedsurg.2006.08.028. J Pediatr Surg. 2006. PMID: 17161194

7

Size of sentinel node metastases predicts other nodal disease and survival in malignant melanoma.

Pearlman NW, McCarter MD, Frank M, Hurtubis C, Merkow RP, Franklin WA, Gonzalez R, Lewis K, Roaten JB, Robinson WA. Pearlman NW, et al. Among authors: roaten jb. Am J Surg. 2006 Dec;192(6):878-81. doi: 10.1016/j.amjsurg.2006.08.062. Am J Surg. 2006. PMID: 17161112

8

Positioning for the Nuss procedure: avoiding brachial plexus injury.

Fox ME, Bensard DD, Roaten JB, Hendrickson RJ. Fox ME, et al. Among authors: roaten jb. Paediatr Anaesth. 2005 Dec;15(12):1067-71. doi: 10.1111/j.1460-9592.2005.01630.x. Paediatr Anaesth. 2005. PMID: 16324025

9

Visceral injuries in nonaccidental trauma: spectrum of injury and outcomes.

Roaten JB, Partrick DA, Bensard DD, Hendrickson RJ, Vertrees T, Sirotnak AP, Karrer FM. Roaten JB, et al. Am J Surg. 2005 Dec;190(6):827-9. doi: 10.1016/j.amjsurg.2005.05.049. Am J Surg. 2005. PMID: 16307928

10

Survival in sentinel lymph node-positive pediatric melanoma.

Roaten JB, Partrick DA, Bensard D, Pearlman N, Gonzalez R, Fitzpatrick J, McCarter MD. Roaten JB, et al. J Pediatr Surg. 2005 Jun;40(6):988-92; discussion 992. doi: 10.1016/j.jpedsurg.2005.03.014. J Pediatr Surg. 2005. PMID: 15991183

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters